ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Novo Nordisk is seeking Chinese regulatory approval for its oral weight loss pill. The company submitted the application to Chinese health authorities. Approval would expand access to the treatment in China's large market.
Tap to vote and see what everyone thinks.
Summary by ByteBrief